医学
免疫球蛋白轻链
心肌病
淀粉样蛋白(真菌学)
内科学
心脏病学
心力衰竭
病理
免疫学
抗体
作者
Frederick Lang,Sergio Teruya,Margaret Cuomo,Alfonsina Mirabal Santos,Jai Radhakrishnan,Suzanne Lentzsch,Rajshekhar Chakraborty,Divaya Bhutani,Mathew S. Maurer
标识
DOI:10.1016/j.cardfail.2024.06.009
摘要
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated benefit in patients with heart failure, but minimal data exists around the use of these medications in amyloid light-chain cardiomyopathy (AL-CM). We performed a retrospective study assessing the safety and efficacy of SGLT2i in AL-CM.
科研通智能强力驱动
Strongly Powered by AbleSci AI